Respiratory health impacts quality of life for adults with OI

2019 ◽  
Author(s):  
Elizabeth Yonko ◽  
Erin Carter ◽  
Robert Sandhaus ◽  
Cathleen Raggio
Keyword(s):  
Quality Of Life ◽  
Respiratory Health ◽  
Health Impacts

Adults face increased asthma risk after infant RSV bronchiolitis and reduced respiratory health-related quality of life after RSV pneumonia

2014 ◽  
Vol 103 (8) ◽  
pp. 850-855 ◽  
Author(s):  
Katri Backman ◽  
Eija Piippo-Savolainen ◽  
Hertta Ollikainen ◽  
Heikki Koskela ◽  
Matti Korppi
Keyword(s):  
Quality Of Life ◽  
Respiratory Health ◽  
Health Related Quality ◽  
Asthma Risk ◽  
Related Quality ◽  
Health Related

Recurrent aphthous stomatitis (RAS): a preliminary within-subject study of quality of life, oral health impacts and personality profiles

2014 ◽  
Vol 44 (4) ◽  
pp. 278-283 ◽  
Author(s):  
Mahmoud K. AL-Omiri ◽  
Jumana Karasneh ◽  
Mohannad M. Alhijawi ◽  
Abdalwhab M. A. Zwiri ◽  
Crispian Scully ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Oral Health ◽  
Recurrent Aphthous Stomatitis ◽  
Aphthous Stomatitis ◽  
Health Impacts ◽  
Personality Profiles

scholarly journals Oral health impacts and quality of life in an urban homeless population

2014 ◽  
Vol 59 (2) ◽  
pp. 234-239 ◽  
Author(s):  
PJ Ford ◽  
S Cramb ◽  
CS Farah
Keyword(s):  
Quality Of Life ◽  
Oral Health ◽  
Health Impacts ◽  
Homeless Population

scholarly journals Ventilated cookstoves associated with improvements in respiratory health-related quality of life in rural Bolivia

2013 ◽  
Vol 36 (3) ◽  
pp. 460-466 ◽  
Author(s):  
Donee Alexander ◽  
Jacqueline Callihan Linnes ◽  
Susan Bolton ◽  
Timothy Larson
Keyword(s):  
Quality Of Life ◽  
Respiratory Health ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Stigma from medication use: an under recognised burden of care

Breathe ◽  
2021 ◽  
Vol 17 (1) ◽  
pp. 210002
Author(s):  
Sonal Kansra ◽  
Rachel Calvert ◽  
Steve Jones
Keyword(s):  
Quality Of Life ◽  
Disease Control ◽  
Respiratory Health ◽  
List Type ◽  
Social Environments ◽  
Burden Of Care ◽  
Children And Young People ◽  
Educational Aims ◽  
Spheres Of Influence

Children with respiratory diseases take treatments for the self-management of symptoms and to maintain disease control. Often, these treatments need to be taken in social environments like school. Respiratory treatments can foster a feeling of difference and stigmatisation, which negatively impact on the quality of life and adherence to treatment. Such perceptions can lead to a less than optimal disease control, a vicious cycle leading to further social exclusion and stigma. This aspect of “burden of treatment” is poorly recognised by clinicians. Recognition of how treatments and clinical practice can contribute to stigma, can help address this burden of care.Educational aimsTo understand the meaning of the term “stigma” within the context of respiratory health conditions and how medication or treatments can contribute to stigma in children and young people.To understand the potential impact of stigma on adherence, disease control and quality of life.To consider strategies to manage the stigma associated with health treatments across spheres of influence.

scholarly journals Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers

2019 ◽  
Vol Volume 14 ◽  
pp. 1813-1824 ◽  
Author(s):  
F.I. Hawari ◽  
N.A. Obeidat ◽  
M. Abu Alhalawa ◽  
Z. Al-Busaidi ◽  
B. Amara ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Respiratory Health ◽  
Cigarette Smokers

Impact of respiratory muscle training on respiratory muscle strength, respiratory function and quality of life in individuals with tetraplegia: a randomised clinical trial

Thorax ◽  
2020 ◽  
Vol 75 (3) ◽  
pp. 279-288 ◽  
Author(s):  
Claire L Boswell-Ruys ◽  
Chaminda R H Lewis ◽  
Nirupama S Wijeysuriya ◽  
Rachel A McBain ◽  
Bonsan Bonne Lee ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Muscle Strength ◽  
Lung Function ◽  
Respiratory Muscle ◽  
Respiratory Health ◽  
Inspiratory Muscle ◽  
Respiratory Muscle Training ◽  
Muscle Training ◽  
Inspiratory Muscle Strength

BackgroundRespiratory complications remain a leading cause of morbidity and mortality in people with acute and chronic tetraplegia. Respiratory muscle weakness following spinal cord injury-induced tetraplegia impairs lung function and the ability to cough. In particular, inspiratory muscle strength has been identified as the best predictor of the likelihood of developing pneumonia in individuals with tetraplegia. We hypothesised that 6 weeks of progressive respiratory muscle training (RMT) increases respiratory muscle strength with improvements in lung function, quality of life and respiratory health.MethodsSixty-two adults with tetraplegia participated in a double-blind randomised controlled trial. Active or sham RMT was performed twice daily for 6 weeks. Inspiratory muscle strength, measured as maximal inspiratory pressure (PImax) was the primary outcome. Secondary outcomes included lung function, quality of life and respiratory health. Between-group comparisons were obtained with linear models adjusting for baseline values of the outcomes.ResultsAfter 6 weeks, there was a greater improvement in PImax in the active group than in the sham group (mean difference 11.5 cmH2O (95% CI 5.6 to 17.4), p<0.001) and respiratory symptoms were reduced (St George Respiratory Questionnaire mean difference 10.3 points (0.01–20.65), p=0.046). Significant improvements were observed in quality of life (EuroQol-Five Dimensional Visual Analogue Scale 14.9 points (1.9–27.9), p=0.023) and perceived breathlessness (Borg score 0.64 (0.11–1.17), p=0.021). There were no significant improvements in other measures of respiratory function (p=0.126–0.979).ConclusionsProgressive RMT increases inspiratory muscle strength in people with tetraplegia, by a magnitude which is likely to be clinically significant. Measurement of baseline PImax and provision of RMT to at-risk individuals may reduce respiratory complications after tetraplegia.Trial registration numberAustralian New Zealand Clinical Trials Registry (ACTRN 12612000929808).

Sign in / Sign up

Export Citation Format

Share Document